Weno Exchange Revenue and Competitors

Austin, TX USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Weno Exchange's estimated annual revenue is currently $870k per year.(i)
  • Weno Exchange's estimated revenue per employee is $87,000

Employee Data

  • Weno Exchange has 10 Employees.(i)
  • Weno Exchange grew their employee count by 11% last year.

Weno Exchange's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$17.5M12112%N/AN/A
#2
$90.4M49924%N/AN/A
#3
$2M20-23%N/AN/A
#4
$226.8M109446%$261MN/A
#5
$406.7M26008%$26.1MN/A
#6
$14.8M102-61%N/AN/A
#7
$8.6M66-1%N/AN/A
#8
$13.2M91-5%$752.5MN/A
#9
$36.5M2296%N/AN/A
#10
$56.6M31223%N/AN/A
Add Company

What Is Weno Exchange?

WENO is an e-Prescribing switch based in Austin, Texas that specializes in routing electronic prescriptions (eRx) between trading partners. When established in 2011, WENO was hailed as an innovative competitor in an otherwise dominated e-prescribing network market. WENO utilizes a patent-pending method, which provides the first and only service enabling electronic prescriptions to be sent to any pharmacy. In addition, WENO offers health IT trading partners a simplified process toward connectivity. WENO also boasts the industry’s highest EHR incentive revenues and pharmacy’s lowest transaction fees. WENO Benefit Services gives participants opportunity to provide patients and prescribers with medication histories and more cost information when they are in the process of selecting a drug, whether the patient prefers to pay cash or take advantage of a 3rd party offer or government program. The WENO Benefit program uses a patent pending method designed to assure health plans, drug sponsors, and pharmacies that their data is shown consistently and used appropriately in the market.

keywords:N/A

N/A

Total Funding

10

Number of Employees

$870k

Revenue (est)

11%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.9M100%N/A
#2
$0.9M10N/AN/A
#3
$0.8M10N/AN/A
#4
$0.8M10N/AN/A
#5
$0.9M10N/AN/A